Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126977891 | 12697789 | 1 | I | 20160525 | 20160830 | 20160830 | PER | US-APOTEX-2016AP008707 | APOTEX | 0.00 | F | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126977891 | 12697789 | 1 | PS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Unknown | 50 ?G, UNK | U | U | 77449 | 50 | UG | TRANSDERMAL SYSTEM | |||||
| 126977891 | 12697789 | 2 | SS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Unknown | 25 ?G, UNK | U | U | 77449 | 25 | UG | TRANSDERMAL SYSTEM | |||||
| 126977891 | 12697789 | 3 | C | FENTANYL. | FENTANYL | 1 | Unknown | 100 ?G, UNK | U | U | 0 | 100 | UG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126977891 | 12697789 | 1 | Pain |
| 126977891 | 12697789 | 3 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126977891 | 12697789 | Activities of daily living impaired | |
| 126977891 | 12697789 | Bedridden | |
| 126977891 | 12697789 | Drug ineffective | |
| 126977891 | 12697789 | Extra dose administered | |
| 126977891 | 12697789 | Pain | |
| 126977891 | 12697789 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |